Mitochondrial Morphology in Patients with End‐stage Renal Disease (ESRD)

renal bone disease among patients with esrd

Renal Bone Disease Among Patients With ESRD

which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. With interest, we read the article by Sidy Secket et al. on the mineral and bone disease in black African hemodialy-sis patients: A report from Senegal. The authors evaluated 118 end-stage renal disease (ESRD) patients under hemo-dialysis and showed that chronic kidney dis...

Risk Factors Associated with End-Stage Renal Disease (ESRD) in Patients With Atherosclerotic Renal Artery Stenosis

The aim of this study was to investigate the risk factors associated with end-stage renal disease (ESRD) in patients with atherosclerotic renal artery stenosis (ARAS). Information about the study participants was extracted from the National Health Insurance Research Database of Taiwan for the years 1999 through 2011. We conducted this retrospective cohort study of patients with ARAS to identify...

Does medical insurance matter in the progression to endstage renal disease among patients with lupus nephritis?

Genomic Damage in Endstage Renal Disease—Contribution of Uremic Toxins

Patients with end-stage renal disease (ESRD), whether on conservative, peritoneal or hemodialysis therapy, have elevated genomic damage in peripheral blood lymphocytes and an increased cancer incidence, especially of the kidney. The damage is possibly due to accumulation of uremic toxins like advanced glycation endproducts or homocysteine. However, other endogenous substances with genotoxic pro...